Amprius Technologies Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | -$0.0244 |
| EPS actual | -$0.0400 |
| EPS Surprise | -63.67% |
| Revenue estimate | 25.723M |
| Revenue actual | 28.536M |
| Revenue Surprise | 10.93% |
| Release date | Mar 04, 2026 |
| EPS estimate | -$0.0380 |
| EPS actual | -$0.180 |
| EPS Surprise | -373.93% |
| Revenue estimate | 22.909M |
| Revenue actual | 25.234M |
| Revenue Surprise | 10.15% |
| Release date | Nov 06, 2025 |
| EPS estimate | -$0.0536 |
| EPS actual | -$0.0307 |
| EPS Surprise | 42.65% |
| Revenue estimate | 16.811M |
| Revenue actual | 21.426M |
| Revenue Surprise | 27.45% |
| Release date | Aug 07, 2025 |
| EPS estimate | -$0.0786 |
| EPS actual | -$0.0523 |
| EPS Surprise | 33.42% |
| Revenue estimate | 12.784M |
| Revenue actual | 15.067M |
| Revenue Surprise | 17.85% |
Last 4 Quarters for Amprius Technologies
Below you can see how AMPX-WT performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $2.09 |
| EPS estimate | -$0.0786 |
| EPS actual | -$0.0523 |
| EPS surprise | 33.42% |
| Date | Price |
|---|---|
| Aug 01, 2025 | $1.45 |
| Aug 04, 2025 | $1.91 |
| Aug 05, 2025 | $2.38 |
| Aug 06, 2025 | $2.04 |
| Aug 07, 2025 | $2.09 |
| Aug 08, 2025 | $2.28 |
| Aug 11, 2025 | $2.13 |
| Aug 12, 2025 | $2.10 |
| Aug 13, 2025 | $2.04 |
| 4 days before | 43.79% |
| 4 days after | -2.16% |
| On release day | 9.35% |
| Change in period | 40.69% |
| Release date | Nov 06, 2025 |
| Price on release | $4.40 |
| EPS estimate | -$0.0536 |
| EPS actual | -$0.0307 |
| EPS surprise | 42.65% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $6.02 |
| Nov 03, 2025 | $5.74 |
| Nov 04, 2025 | $4.77 |
| Nov 05, 2025 | $5.35 |
| Nov 06, 2025 | $4.40 |
| Nov 07, 2025 | $5.05 |
| Nov 10, 2025 | $5.73 |
| Nov 11, 2025 | $5.21 |
| Nov 12, 2025 | $5.05 |
| 4 days before | -26.91% |
| 4 days after | 14.77% |
| On release day | 14.77% |
| Change in period | -16.11% |
| Release date | Mar 04, 2026 |
| Price on release | $5.14 |
| EPS estimate | -$0.0380 |
| EPS actual | -$0.180 |
| EPS surprise | -373.93% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $4.61 |
| Feb 27, 2026 | $4.41 |
| Mar 02, 2026 | $4.73 |
| Mar 03, 2026 | $4.71 |
| Mar 04, 2026 | $5.14 |
| Mar 05, 2026 | $6.30 |
| Mar 06, 2026 | $7.01 |
| Mar 09, 2026 | $7.55 |
| Mar 10, 2026 | $7.97 |
| 4 days before | 11.39% |
| 4 days after | 55.21% |
| On release day | 22.69% |
| Change in period | 72.89% |
| Release date | May 07, 2026 |
| Price on release | $6.33 |
| EPS estimate | -$0.0244 |
| EPS actual | -$0.0400 |
| EPS surprise | -63.67% |
| Date | Price |
|---|---|
| May 01, 2026 | $9.44 |
| May 04, 2026 | $8.95 |
| May 05, 2026 | $9.91 |
| May 06, 2026 | $10.77 |
| May 07, 2026 | $6.33 |
| May 08, 2026 | $6.71 |
| May 11, 2026 | $7.23 |
| May 12, 2026 | $7.58 |
| May 13, 2026 | $6.81 |
| 4 days before | -32.95% |
| 4 days after | 7.58% |
| On release day | 6.00% |
| Change in period | -27.86% |
Amprius Technologies Earnings Call Transcript Summary of Q1 2026
Amprius reported a strong Q1 2026 with revenue of $28.5M (up 153% YoY, +13% sequential), driven by growing adoption of its second-generation SiCore silicon-anode cells across defense UAS, international customers, and a new light electric vehicle (2/3-wheeler) multi-quarter $21M order in China. Management raised 2026 revenue guidance to at least $130M (up $5M) and reiterated expectations for adjusted EBITDA of at least $4M and a net loss no greater than $8M. Gross margin in Q1 was 20% (about 22% ex the one-month Colorado cost carryover); management expects to reach ~25% full-year gross margin as mix and logistics improve and additional manufacturing capacity in Korea and the U.S. comes online. Cash was $62.4M at quarter end (down from $90.5M) after $37.3M in uses, including $20M to settle the Colorado lease obligation (avoiding a much larger liability) and higher accounts receivable tied to revenue growth. The Defense Innovation Unit (DIU) contract was expanded to $18.1M to fund development and standardization of pouch and cylindrical cells for NDAA-compliant supply, supporting U.S.-based production plans (including progress with Nanotech for 21700 cylindrical cells). Management is actively optimizing the capital structure: an announced agreement to exchange ~$7.1M of public warrants for common shares is expected to materially reduce potential dilution (management cites roughly $70M of dilution avoided). Key risks remain execution on manufacturing scale-up and margin recovery during the SiMaxx phaseout, but the company emphasizes growing U.S. defense demand, expanding OEM wins, progress on NDAA compliance/supply agreements, and commercialization momentum into robotics, satellites/space, EV light vehicles, and eVTOL.
Sign In
Buy AMPX-WT